Literature DB >> 27472471

Towards longitudinal mapping of extracellular pH in gliomas.

Yuegao Huang1,2, Daniel Coman3,4, Peter Herman3,4, Jyotsna U Rao3,4, Samuel Maritim5, Fahmeed Hyder6,7,8.   

Abstract

Biosensor imaging of redundant deviation in shifts (BIRDS), an ultrafast chemical shift imaging technique, requires infusion of paramagnetic probes such as 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis methylene phosphonate (DOTP(8-) ) complexed with thulium (Tm(3+) ) ion (i.e. TmDOTP(5-) ), where the pH-sensitive resonances of hyperfine-shifted non-exchangeable protons contained within the paramagnetic probe are detected. While imaging extracellular pH (pHe ) with BIRDS meets an important cancer research need by mapping the intratumoral-peritumoral pHe gradient, the surgical intervention used to raise the probe's plasma concentration limits longitudinal scans on the same subject. Here we describe using probenecid (i.e. an organic anion transporter inhibitor) to temporarily restrict renal clearance of TmDOTP(5-) , thereby facilitating molecular imaging by BIRDS without surgical intervention. Co-infusion of probenecid with TmDOTP(5-) increased the probe's distribution into various organs, including the brain, compared with infusing TmDOTP(5-) alone. In vivo BIRDS data using the probenecid-TmDOTP(5-) co-infusion method in rats bearing RG2, 9 L, and U87 brain tumors showed intratumoral-peritumoral pHe gradients that were unaffected by the probe dose. This co-infusion method can be used for pHe mapping with BIRDS in preclinical models for tumor characterization and therapeutic monitoring, given the possibility of repeated scans with BIRDS (e.g. over days and even weeks) in the same subject. The longitudinal pHe readout by the probenecid-TmDOTP(5-) co-infusion method for BIRDS adds translational value in tumor assessment and treatment.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  CEST; extravasation; metastasis; permeability; renal ligation; uric acid reducer

Mesh:

Substances:

Year:  2016        PMID: 27472471      PMCID: PMC5035200          DOI: 10.1002/nbm.3578

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  51 in total

1.  Acid treatment of melanoma cells selects for invasive phenotypes.

Authors:  Raymond E Moellering; Kvar C Black; Chetan Krishnamurty; Brenda K Baggett; Phillip Stafford; Matthew Rain; Robert A Gatenby; Robert J Gillies
Journal:  Clin Exp Metastasis       Date:  2008-02-27       Impact factor: 5.150

2.  The effect of probenecid on the renal tubular excretion of benzylpenicillin.

Authors:  D Overbosch; C Van Gulpen; J Hermans; H Mattie
Journal:  Br J Clin Pharmacol       Date:  1988-01       Impact factor: 4.335

Review 3.  Diffusion tensor and perfusion imaging of brain tumors in high-field MR imaging.

Authors:  Seung-Koo Lee
Journal:  Neuroimaging Clin N Am       Date:  2012-03-12       Impact factor: 2.264

4.  Organic anion transporter 3 mediates the efflux transport of an amphipathic organic anion, dehydroepiandrosterone sulfate, across the blood-brain barrier in mice.

Authors:  Mari Miyajima; Hiroyuki Kusuhara; Miki Fujishima; Yasuhisa Adachi; Yuichi Sugiyama
Journal:  Drug Metab Dispos       Date:  2011-02-16       Impact factor: 3.922

Review 5.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

6.  Lanthanide ion (III) complexes of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraaminophosphonate for dual biosensing of pH with chemical exchange saturation transfer (CEST) and biosensor imaging of redundant deviation in shifts (BIRDS).

Authors:  Yuegao Huang; Daniel Coman; Meser M Ali; Fahmeed Hyder
Journal:  Contrast Media Mol Imaging       Date:  2014-05-06       Impact factor: 3.161

7.  Brain temperature by Biosensor Imaging of Redundant Deviation in Shifts (BIRDS): comparison between TmDOTP5- and TmDOTMA-.

Authors:  Daniel Coman; Hubert K Trubel; Fahmeed Hyder
Journal:  NMR Biomed       Date:  2010-04       Impact factor: 4.044

8.  In situ 3D magnetic resonance metabolic imaging of microwave-irradiated rodent brain: a new tool for metabolomics research.

Authors:  Robin A de Graaf; Golam M I Chowdhury; Peter B Brown; Douglas L Rothman; Kevin L Behar
Journal:  J Neurochem       Date:  2009-02-07       Impact factor: 5.372

Review 9.  Clinical pharmacokinetics of probenecid.

Authors:  R F Cunningham; Z H Israili; P G Dayton
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

Review 10.  MR - eyes for cancer: looking within an impenetrable disease.

Authors:  Marie-France Penet; Dmitri Artemov; Keyvan Farahani; Zaver M Bhujwalla
Journal:  NMR Biomed       Date:  2013-07       Impact factor: 4.044

View more
  12 in total

1.  Extracellular pH mapping of liver cancer on a clinical 3T MRI scanner.

Authors:  Daniel Coman; Dana C Peters; John J Walsh; Lynn J Savic; Steffen Huber; Albert J Sinusas; MingDe Lin; Julius Chapiro; R Todd Constable; Douglas L Rothman; James S Duncan; Fahmeed Hyder
Journal:  Magn Reson Med       Date:  2019-11-05       Impact factor: 4.668

2.  Extracellular pH Mapping as Therapeutic Readout of Drug Delivery in Glioblastoma.

Authors:  John J Walsh; Fahmeed Hyder
Journal:  Methods Mol Biol       Date:  2022

3.  Phosphocreatine Levels in the Left Thalamus Decline during Wakefulness and Increase after a Nap.

Authors:  Ali Gordji-Nejad; Andreas Matusch; Shumei Li; Tina Kroll; Simone Beer; David Elmenhorst; Andreas Bauer
Journal:  J Neurosci       Date:  2018-10-03       Impact factor: 6.167

4.  Molecular Imaging of Extracellular Tumor pH to Reveal Effects of Locoregional Therapy on Liver Cancer Microenvironment.

Authors:  Daniel Coman; Julius Chapiro; Lynn Jeanette Savic; Isabel Theresa Schobert; Dana Peters; John J Walsh; Fabian Max Laage-Gaupp; Charlie Alexander Hamm; Nina Tritz; Luzie A Doemel; MingDe Lin; Albert Sinusas; Todd Schlachter; James S Duncan; Fahmeed Hyder
Journal:  Clin Cancer Res       Date:  2019-10-03       Impact factor: 12.531

5.  Imaging Extracellular Acidification and Immune Activation in Cancer.

Authors:  Fahmeed Hyder; Daniel Coman
Journal:  Curr Opin Biomed Eng       Date:  2021-03-05

6.  Temozolomide arrests glioma growth and normalizes intratumoral extracellular pH.

Authors:  Jyotsna U Rao; Daniel Coman; John J Walsh; Meser M Ali; Yuegao Huang; Fahmeed Hyder
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

7.  Mapping Extracellular pH of Gliomas in Presence of Superparamagnetic Nanoparticles: Towards Imaging the Distribution of Drug-Containing Nanoparticles and Their Curative Effect on the Tumor Microenvironment.

Authors:  Samuel Maritim; Daniel Coman; Yuegao Huang; Jyotsna U Rao; John J Walsh; Fahmeed Hyder
Journal:  Contrast Media Mol Imaging       Date:  2017-11-22       Impact factor: 3.161

8.  High-resolution label-free 3D mapping of extracellular pH of single living cells.

Authors:  Yanjun Zhang; Yasufumi Takahashi; Sung Pil Hong; Fengjie Liu; Joanna Bednarska; Philip S Goff; Pavel Novak; Andrew Shevchuk; Sahana Gopal; Iros Barozzi; Luca Magnani; Hideki Sakai; Yoshimoto Suguru; Takuto Fujii; Alexander Erofeev; Peter Gorelkin; Alexander Majouga; Dominik J Weiss; Christopher Edwards; Aleksandar P Ivanov; David Klenerman; Elena V Sviderskaya; Joshua B Edel; Yuri Korchev
Journal:  Nat Commun       Date:  2019-12-06       Impact factor: 14.919

Review 9.  Brain Tumor Diagnostics and Therapeutics with Superparamagnetic Ferrite Nanoparticles.

Authors:  Fahmeed Hyder; S Manjura Hoque
Journal:  Contrast Media Mol Imaging       Date:  2017-12-11       Impact factor: 3.161

10.  Tumor-targeted pH-low insertion peptide delivery of theranostic gadolinium nanoparticles for image-guided nanoparticle-enhanced radiation therapy.

Authors:  Wu Liu; John Deacon; Huagang Yan; Bo Sun; Yanfeng Liu; Denise Hegan; Qin Li; Daniel Coman; Maxime Parent; Fahmeed Hyder; Kenneth Roberts; Ravinder Nath; Olivier Tillement; Donald Engelman; Peter Glazer
Journal:  Transl Oncol       Date:  2020-08-04       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.